Amgen Ventures Llc - Net Worth and Insider Trading
Amgen Ventures Llc Net Worth
The estimated net worth of Amgen Ventures Llc is at least $491,165 dollars as of 2024-09-24. Amgen Ventures Llc is the 10% Owner of Epizyme Inc and owns about 334,126 shares of Epizyme Inc (EPZM) stock worth over $491,165. Details can be seen in Amgen Ventures Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amgen Ventures Llc has not made any transactions after 2013-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amgen Ventures Llc
Amgen Ventures Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amgen Ventures Llc owns 2 companies in total, including TetraLogic Pharmaceuticals Corp (TLOG) , and Epizyme Inc (EPZM) .
Click here to see the complete history of Amgen Ventures Llc’s form 4 insider trades.
Insider Ownership Summary of Amgen Ventures Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TLOG | TetraLogic Pharmaceuticals Corp | 2013-12-17 | 10 percent owner |
| EPZM | Epizyme Inc | 2013-06-05 | 10 percent owner |
Amgen Ventures Llc Latest Holdings Summary
Amgen Ventures Llc currently owns a total of 1 stock. Amgen Ventures Llc owns 334,126 shares of Epizyme Inc (EPZM) as of June 5, 2013, with a value of $491,165.
Latest Holdings of Amgen Ventures Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EPZM | Epizyme Inc | 2013-06-05 | 334,126 | 1.47 | 491,165 |
Holding Weightings of Amgen Ventures Llc
Amgen Ventures Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Amgen Ventures Llc has made a total of 0 transactions in Epizyme Inc (EPZM) over the past 5 years. The most-recent trade in Epizyme Inc is the acquisition of 16,666 shares on June 5, 2013, which cost Amgen Ventures Llc around $249,990.
Insider Trading History of Amgen Ventures Llc
- 1
Amgen Ventures Llc Trading Performance
GuruFocus tracks the stock performance after each of Amgen Ventures Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amgen Ventures Llc is 15.62%. GuruFocus also compares Amgen Ventures Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amgen Ventures Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amgen Ventures Llc's insider trading performs compared to the benchmark.
Performance of Amgen Ventures Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.11 | | | | | |
| Relative Return to S&P 500(%) | 16.68 | | | | | |
Amgen Ventures Llc Ownership Network
Amgen Ventures Llc Owned Company Details
What does TetraLogic Pharmaceuticals Corp do?
Who are the key executives at TetraLogic Pharmaceuticals Corp?
Amgen Ventures Llc is the 10 percent owner of TetraLogic Pharmaceuticals Corp. Other key executives at TetraLogic Pharmaceuticals Corp include other: See Remarks Hudson Bay Capital Management Lp , other: See Remarks Lazard Asset Management Llc , and other: See Remarks Nomura Holdings Inc .
TetraLogic Pharmaceuticals Corp (TLOG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TetraLogic Pharmaceuticals Corp (TLOG)'s detailed insider trading history can be found in Insider Trading Tracker table.
TetraLogic Pharmaceuticals Corp Insider Transactions
Amgen Ventures Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Amgen Ventures Llc. You might contact Amgen Ventures Llc via mailing address: One Amgen Center Drive Thousand Oaks Ca 91320-1799.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
